Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hein Putter

Showing results (461-470 of 512) with videos related to

Pageof 52
Sort By:
Circulation|March 19, 2019
Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis PatientsJ Wouter Jukema, Rohit J Timal, Joris I Rotmans, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysisWillemien van de Water, Duveken B Y Fontein, Johanna G H van Nes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysisDuveken B Y Fontein, Caroline Seynaeve, Peyman Hadji, et al.
Annals of Surgery|January 20, 2023
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO TrialEsmée A Dijkstra, Per J Nilsson, Geke A P Hospers, et al.
Circulation. Cardiovascular Genetics|March 1, 2012
Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort studyAnika A M Vaarhorst, Yingchang Lu, Bastiaan T Heijmans, et al.
The Lancet. Oncology|July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trialStephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 29, 2021
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trialAstrid E Slagter, Marieke A Vollebergh, Irene A Caspers, et al.
Retina (Philadelphia, Pa.)|March 13, 2018
CLINICAL AND GENETIC CHARACTERISTICS OF MALE PATIENTS WITH RPGR-ASSOCIATED RETINAL DYSTROPHIES: A Long-Term Follow-up StudyMays Talib, Mary J van Schooneveld, Alberta A Thiadens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL TrialsIris Noordhoek, Erik J Blok, Elma Meershoek-Klein Kranenbarg, et al.
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Pageof 52

Showing results (461-470 of 512) with videos related to

Sort By:
Pageof 52
Circulation|March 19, 2019
Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis PatientsJ Wouter Jukema, Rohit J Timal, Joris I Rotmans, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysisWillemien van de Water, Duveken B Y Fontein, Johanna G H van Nes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysisDuveken B Y Fontein, Caroline Seynaeve, Peyman Hadji, et al.
Annals of Surgery|January 20, 2023
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO TrialEsmée A Dijkstra, Per J Nilsson, Geke A P Hospers, et al.
Circulation. Cardiovascular Genetics|March 1, 2012
Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort studyAnika A M Vaarhorst, Yingchang Lu, Bastiaan T Heijmans, et al.
The Lancet. Oncology|July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trialStephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 29, 2021
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trialAstrid E Slagter, Marieke A Vollebergh, Irene A Caspers, et al.
Retina (Philadelphia, Pa.)|March 13, 2018
CLINICAL AND GENETIC CHARACTERISTICS OF MALE PATIENTS WITH RPGR-ASSOCIATED RETINAL DYSTROPHIES: A Long-Term Follow-up StudyMays Talib, Mary J van Schooneveld, Alberta A Thiadens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL TrialsIris Noordhoek, Erik J Blok, Elma Meershoek-Klein Kranenbarg, et al.
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Pageof 52